Raja Kumaraguru
Stock Analyst at Roth MKM
(n/a)
# 4,840
Out of 5,005 analysts
5
Total ratings
n/a
Success rate
-43.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Raja Kumaraguru
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAIN Rain Enhancement Technologies Holdco | Downgrades: Neutral | $1.2 | $4.83 | -75.16% | 1 | May 30, 2023 | |
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $480 | $2.00 | +23,960.15% | 1 | Mar 12, 2021 | |
| CNSP CNS Pharmaceuticals | Initiates: Buy | $9,000,000 | $8.96 | +100,502,412.56% | 1 | Feb 2, 2021 | |
| FBRX Forte Biosciences | Initiates: Buy | $2,250 | $15.49 | +14,425.50% | 1 | Aug 28, 2020 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $210 | $99.39 | +111.29% | 1 | Feb 19, 2020 |
Rain Enhancement Technologies Holdco
May 30, 2023
Downgrades: Neutral
Price Target: $1.2
Current: $4.83
Upside: -75.16%
NLS Pharmaceutics AG
Mar 12, 2021
Initiates: Buy
Price Target: $480
Current: $2.00
Upside: +23,960.15%
CNS Pharmaceuticals
Feb 2, 2021
Initiates: Buy
Price Target: $9,000,000
Current: $8.96
Upside: +100,502,412.56%
Forte Biosciences
Aug 28, 2020
Initiates: Buy
Price Target: $2,250
Current: $15.49
Upside: +14,425.50%
Monopar Therapeutics
Feb 19, 2020
Initiates: Buy
Price Target: $210
Current: $99.39
Upside: +111.29%